Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120
Authors:
- Geoffrey J. GorseGGGeoffrey J. Gorse
- Gira B. PatelGPGira B. Patel
- Mahendra D. MandavaMMMahendra D. Mandava
- J.ALan ArbuckleJAJ.ALan Arbuckle
- Timothy M. DoyleTDTimothy M. Doyle
- Robert B. BelsheRBRobert B. Belshe
- 1 February 2001
- Vol. 19 (13-14) , 1806-1819
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (N01-AI-45211, U01-AI-48021)
This publication has 66 references indexed in Scilit:
- Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 1999
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administrationVaccine, 1998
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsJournal of Experimental Medicine, 1997
- Cytokines and infectious diseasesImmunology Today, 1997
- Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infectionAIDS, 1995
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccineThe Lancet, 1993
- Interleukin-10Annual Review of Immunology, 1993
- Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).Journal of Experimental Medicine, 1987